Initial studies demonstrated that phosphorylation of this site results in a pro-apoptotic form of RelA in response to induction of the ARF tumour suppressor or treatment with the chemotherapeutic drug cisplatin [15–17]. The gene discussed is CDKN2A; the disease is neoplasm.